{"id":"W2147791981","doi":"10.1136/annrheumdis-2012-201766","title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)","year":2012,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":532,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Cilag; Procter and Gamble; Chugai Pharmaceutical; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Sanofi; Abbott Laboratories","keywords":"Adalimumab; Medicine; BASDAI; Ankylosing spondylitis; Placebo; Internal medicine; Spondylitis; Clinical endpoint; Visual analogue scale; Physical therapy; Randomized controlled trial; Arthritis; Disease; Psoriatic arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005094089,0.000219462,0.001340919,0.0001621402,0.00005778922,0.000004365891,0.000104659,0.00005303274,0.00002251359],"category_scores_gemma":[0.001415304,0.0001293751,0.0003451642,0.0003083894,0.0003636505,0.00009843944,0.00006071358,0.00007008782,5.247912e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001111384,"about_ca_system_score_gemma":0.0000747509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001177427,"about_ca_topic_score_gemma":0.00001752237,"domain_scores_codex":[0.9977758,0.0002251908,0.001032369,0.0001923893,0.0004809518,0.0002932811],"domain_scores_gemma":[0.9977478,0.0008702439,0.0006040983,0.0004552508,0.0001728782,0.0001497171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8742079,0.004274786,0.1146279,0.0002631404,0.0008454355,0.00000124988,0.0005894645,0.000005829584,0.000004242871,0.00001967889,0.00006909137,0.005091235],"study_design_scores_gemma":[0.5452011,0.001399644,0.4515831,0.001231056,0.0003570387,8.093692e-7,0.00007734921,0.000005472411,0.00004480907,0.00003010299,0.000004754109,0.00006482412],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910232,0.002967213,8.836899e-7,0.0001489354,0.000119805,0.005257896,0.0002620294,0.000007867426,0.0002121976],"genre_scores_gemma":[0.9991155,0.000587776,0.00003826925,0.00002162644,0.00002183813,0.0001559593,0.00002967721,0.00001599722,0.00001335246],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3369552,"threshold_uncertainty_score":0.5275765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01293949533890286,"score_gpt":0.2608029505348781,"score_spread":0.2478634551959752,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}